Cite
HARVARD Citation
Zhu, S. et al. (2022). DNA‐repair status should be assessed in treatment‐emergent neuroendocrine prostate cancer before platinum‐based therapy. Prostate. 82 (4), pp. 464-474. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhu, S. et al. (2022). DNA‐repair status should be assessed in treatment‐emergent neuroendocrine prostate cancer before platinum‐based therapy. Prostate. 82 (4), pp. 464-474. [Online].